Professor of Surgery, MD Anderson Cancer Ctr., Univ. of Texas
General Surgery
Dr. Richard E. Royal, MD
|
|
Give Review
Richard E. Royal, MD is an expert in the field of General Surgery. He went to Oregon Health & Science University School of Medicine. He over the years received 1 awards: "Fellow (FACS)". Richard Royal is a published doctor and has 62 publications published. The lastest was: 'A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a hum...' Richard E. Royal accepts Medicare.
Publications
- Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.
- A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous AdenoCarcinoma of the Appendix.
- A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using norm...
- Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
- The relationship between blood IL-12p40 level and melanoma progression.
- Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the deLivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in...
- Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance Strat...
- Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.
- Improving the AJCC/TNM staging for adenoCarcinomas of the appendix: the prognostic impact of histological grade.
- High-level Microsatellite Instability in Appendiceal Carcinomas.
- Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile Carcinoma.
- Treatment factors associated with long-term survival after cytoreductive surgery and Regional chemotherapy for patients with malignant peritoneal mesothelioma.
- A novel nomogram for peritoneal mesothelioma predicts survival.
- Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients.
- Pathologic complete response in poorly differentiated adenoCarcinomas of the appendix: A case series.
- Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma.
- Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenoCarcinoma.
- Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.
- Gene therapy with human and mouse T-cell receptors mediates Cancer regression and targets normal tissues expressing cognate antigen.
- Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines.
- High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective Analysis of response and survival in patients treated in the surgery bra...
- Diagnosis and management of peritoneal Carcinomatosis arising from adenoCarcinoma of the colon and rectum.
- Combining agents that target the tumor microenvironment improves the efficacy of antiCancer therapy.
- Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.
- Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenoCarcinoma.
- Determination of the elimination half-life of fibroblast growth factor-23.
- Cancer regression in patients after transfer of genetically engineered lymphocytes.
- Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.
- Enterocolitis in patients with Cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
- Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines.
- Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
- Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal Cancer.
- Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.
- Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
- Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
- Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
- Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs.
- Advanced proximal colon Cancer.
- Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.
- Recognition of human colon Cancer by T cells transduced with a chimeric receptor gene.
- A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a hum...
- Living renal donation in the African-American community.
- Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
- Correlates of response to IL-2 therapy in patients treated for metastatic renal Cancer and melanoma.
- Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
- Repair of mucosal perforation during pyloromyotomy: surgeon's choice.
- Thyroid dysfunction in 281 patients with metastatic melanoma or renal Carcinoma treated with interleukin-2 alone.
- Extended myectomy-myotomy. A therapeutic alternative for total Intestinal aganglionosis.
- A comparative study of neonates'' umbilical cord management .
- Luminal narrowing after autoanastomosis and intraluminal slough in intussusception: a case report and historical review.
- Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell Cancer associated with enteritis and hypophysitis.
- Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.
- Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal Carcinomatosis: hemodynamic, metabolic, and anesthe...
- Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
- Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate Cancer cell lines.
- Prospective assessment of postoperative complications and associated costs following Inguinal lymph node dissection (ILND) in melanoma patients.
- Effect of caesarean section on Breast milk transfer to the normal term newborn over the first week of life.
- Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-Analysis.
- Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenoCarcinomas of the appendix.
- A pilot feasibility study of TNFerade⢠biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal Cancer.
- Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.
Schools
Or Hlth Sci Univ Sch Of Med
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Biopsy of Breast
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anorectal Abscess
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of Maryland -
Cincinnati Children's Hospital Medical Center -
Wellspan York Hospital -
Oregon Health & Science University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1598901316 | |
| NPPES Provider LastName | ROYAL | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 770304008 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 83.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 22.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598901316 |
| Last Name Of The Provider | ROYAL |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Jason Au, MD |
|
Dr. William M. Ratliff, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles W. Hartin Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Neal R. Reisman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. H R. Bailey, MD |
|
Dr. Minh T. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John G. Norris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrienne P. Floyd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald P. Lesslie III, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elegy L. Etter II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amit Agarwal, MD |
|
|
Dr. Steven J. Kronowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin M. Aertker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Azim A. Karim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Maoz, MD |
|
|
Kristina M. Scroggins |
|
|
Dr. Ashley K. Cayo, MD
This Doctor is OpenDoctor Recommended.
|